搜索筛选:
搜索耗时0.0790秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
,The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons fo
[期刊论文] 作者：Carlo Sposito,Vincenzo Mazzaferro,
来源：肝胆外科与营养 年份：2018
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma (HCC) represents near...
[期刊论文] 作者：Carlo Sposito,Stefano Di Sandr,
来源：世界胃肠病学杂志：英文版 年份：2016
AIM To develop a prognostic scoring system for overall survival(OS) of patients undergoing liver resection(LR) for hepatocellular carcinoma(HCC).METHODS Consecu...
[期刊论文] 作者：Carlo Sposito,Stefano Di Sandro,Federica Brunero,Vincenzo Buscemi,Carlo Battiston,Andrea Lauterio,Marco,
来源：World Journal of Gastroenterology 年份：2016
AIM To develop a prognostic scoring system for overall survival(OS) of patients undergoing liver resection(LR) for hepatocellular carcinoma(HCC).METHODS Consecu...
[期刊论文] 作者：Alessandro Cucchetti,Carlo Sposito,Antonio Daniele Pinna,Davide Citterio,Matteo Cescon,Marco Bongini,,
来源：World Journal of Gastroenterology 年份：2017
AIM To investigate death for liver failure and for tumor recurrence as competing events after hepatectomy of hepatocellular carcinoma.METHODS Data from 864 cirr...
相关搜索：
